Scholars Central

OtherPublished 26 Jul 2016

Alefacept

Authors: Alan Menter, Jennifer C Cather

Clinical Practice

Volume 2 · Issue 1 · Pages 23

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Plaque psoriasis is a chronic inflammatory and hyperproliferative skin disease characterized by an increase in memory effector T-cells within psoriatic lesions. An increased understanding of the pathophysiology of psoriasis coupled with biotechnologic advances has led to the development of more specific targeted therapies. These therapies have the potential to provide a specific therapeutic intervention while avoiding potential adverse events associated with traditional systemic agents. Alefacept is a novel biologic agent that selectively reduces memory T-cells whilst leaving naive T-cell populations intact. This article reviews the clinical profile of alefacept in the treatment of psoriasis and other emerging indications. Emphasis is on the results of recently published data designed to clarify the optimal use of this promising new therapeutic option.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Practice.

All its articles

Article · 28 Mar 2025

Using

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Alan Menter”
  • BylineArticles whose byline prints “Jennifer C Cather”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels